Notably, TGFA levels were markedly elevated in WHO grade 2 gliomas compared to grades 3–4 (Figure 4A) and in tumors with 1p/19q co-deletion versus non-codeleted cases (Figure 4B), aligning with TCGA and CGGA database findings (Figure 4C). The gene discussed is TGFA; the disease is central nervous system cancer.